Carmela Rita Balistreri1, Claudia Leonarda Ammoscato2, Letizia Scola1, Tiziana Fragapane3, Rosa Maria Giarratana1, Domenico Lio1, Maria Piccione2. 1. Clinical Pathology, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90100 Palermo, Italy. 2. Regional Reference Center for the Control and Treatment of Down Syndrome and Other Chromosomal and Genetic Diseases, Medical Genetics University of Palermo, Villa Sofia/Cervello-United Hospitals, 90100 Palermo, Italy. 3. Department of Neonatology, University Hospital Galway, h91 Galway, Ireland.
Abstract
BACKGROUND: Congenital heart defects (CHDs) are present in about 40-60% of newborns with Down syndrome (DS). Patients with DS can also develop acquired cardiac disorders. Mouse models suggest that a critical 3.7 Mb region located on human chromosome 21 (HSA21) could explain the association with CHDs. This region includes a cluster of genes (IFNAR1, IFNAR2, IFNGR2, IL10RB) encoding for interferon receptors (IFN-Rs). Other genes located on different chromosomes, such as the vascular endothelial growth factor A (VEGFA), have been shown to be involved in cardiac defects. So, we investigated the association between single nucleotide polymorphisms (SNPs) in IFNAR2, IFNGR2, IL10RB and VEGFA genes, and the presence of CHDs or acquired cardiac defects in patients with DS. METHODS: Individuals (n = 102) with DS, and age- and gender-matched controls (n = 96), were genotyped for four SNPs (rs2229207, rs2834213, rs2834167 and rs3025039) using KASPar assays. RESULTS: We found that the IFNGR2 rs2834213 G homozygous genotype and IL10RB rs2834167G-positive genotypes were more common in patients with DSand significantly associated with heart disorders, while VEGFA rs3025039T-positive genotypes (T/*) were less prevalent in patients with CHDs. CONCLUSIONS: We identified some candidate risk SNPs for CHDs and acquired heart defects in DS. Our data suggest that a complex architecture of risk alleles with interplay effects may contribute to the high variability of DS phenotypes.
BACKGROUND:Congenital heart defects (CHDs) are present in about 40-60% of newborns with Down syndrome (DS). Patients with DS can also develop acquired cardiac disorders. Mouse models suggest that a critical 3.7 Mb region located on human chromosome 21 (HSA21) could explain the association with CHDs. This region includes a cluster of genes (IFNAR1, IFNAR2, IFNGR2, IL10RB) encoding for interferon receptors (IFN-Rs). Other genes located on different chromosomes, such as the vascular endothelial growth factor A (VEGFA), have been shown to be involved in cardiac defects. So, we investigated the association between single nucleotide polymorphisms (SNPs) in IFNAR2, IFNGR2, IL10RB and VEGFA genes, and the presence of CHDs or acquired cardiac defects in patients with DS. METHODS: Individuals (n = 102) with DS, and age- and gender-matched controls (n = 96), were genotyped for four SNPs (rs2229207, rs2834213, rs2834167 and rs3025039) using KASPar assays. RESULTS: We found that the IFNGR2rs2834213 G homozygous genotype and IL10RB rs2834167G-positive genotypes were more common in patients with DSand significantly associated with heart disorders, while VEGFA rs3025039T-positive genotypes (T/*) were less prevalent in patients with CHDs. CONCLUSIONS: We identified some candidate risk SNPs for CHDs and acquired heart defects in DS. Our data suggest that a complex architecture of risk alleles with interplay effects may contribute to the high variability of DS phenotypes.
Entities:
Keywords:
Down syndrome; IFNR; SNPs; VEGFA; heart defects
Authors: Marcia H Tanaka; Elisa M A Giro; Lícia B Cavalcante; Juliana R Pires; Luciano H Apponi; Sandro R Valentini; Denise M P Spolidório; Marisa V Capela; Carlos Rossa; Raquel M Scarel-Caminaga Journal: Cytokine Date: 2012-09-18 Impact factor: 3.861
Authors: Martin D Burkhalter; Arthi Sridhar; Pedro Sampaio; Raquel Jacinto; Martina S Burczyk; Cornelia Donow; Max Angenendt; Maja Hempel; Paul Walther; Petra Pennekamp; Heymut Omran; Susana S Lopes; Stephanie M Ware; Melanie Philipp Journal: J Clin Invest Date: 2019-05-16 Impact factor: 14.808
Authors: King-Hwa Ling; Chelsee A Hewitt; Kai-Leng Tan; Pike-See Cheah; Sharmili Vidyadaran; Mei-I Lai; Han-Chung Lee; Ken Simpson; Lavinia Hyde; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott Journal: BMC Genomics Date: 2014-07-22 Impact factor: 3.969
Authors: Leslye Venegas-Zamora; Francisco Bravo-Acuña; Francisco Sigcho; Wileidy Gomez; José Bustamante-Salazar; Zully Pedrozo; Valentina Parra Journal: Front Genet Date: 2022-01-18 Impact factor: 4.599